|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
|
|---|---|---|---|---|
| Revenues | ||||
| Cost of products sold | ||||
| Gross Profit | ||||
| Operating expenses: | ||||
| Selling and administrative expense | ||||
| Research and development expense | ||||
| Impairment expense | ||||
| Other operating expenses | ||||
| Total Operating Expenses | ||||
| Operating Income | ||||
| Interest expense, net | ||||
| Other income (expense), net | ||||
| Income Before Income Taxes | ||||
| Income tax provision (benefit) | ||||
| Net Income | ||||
| Net Income per common share: | ||||
| Basic (in dollars per share) | ||||
| Diluted (in dollars per share) |
Loading...
